GENEREX BIOTECHNOLOGY CORP — Form D

GENEREX BIOTECHNOLOGY CORP of TORONTO ONTARIO CANADA, A1, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-07. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
James H Anderson, Jr., M.D.DirectorTORONTO, A6
John P BarrattDirectorTORONTO, A6
Mark A FletcherDirectorMinneapolis, MN
Nola E MastersonDirectorBloomfield Hills, MI
Brian T McGeeDirectorTORONTO, A6
Eric E von Hofe, Ph.D.DirectorTORONTO, A6
David H Brusegard, Ph.D.Executive OfficerTORONTO, A6
Stephen H FellowsExecutive OfficerTORONTO, A6
Mark A FletcherExecutive OfficerMinneapolis, MN
James AndersonDirectorSouthfield, MI
Craig EagleDirectorGrasonville, MD
Terry ThompsonExecutive OfficerLincoln, NE
Brian McGeeDirectorBOCA RATON, FL
Anthony CrisciExecutive OfficerMiramar, FL
Jason TerrellExecutive OfficerMiramar, FL
Mark PriolettiDirectorMiramar, FL
Lawrence SalvoDirectorMiramar, FL
Andrew RoDirectorMiramar, FL
Andrew RoExecutive OfficerMiramar, FL
Mark CorraoExecutive OfficerMiramar, FL
Richard PurcellExecutive OfficerMiramar, FL
Joseph MoscatoDirectorMiramar, FL
Joseph MoscatoExecutive OfficerMiramar, FL
Brian T. McGeeDirectorTORONTO, A6
James H. Anderson, Jr., M.D.DirectorTORONTO, A6

Other filings by this issuer (2)

FiledFormOfferingSold
2020-09-11D$2.0M
2012-09-05D$750K$750K

More